These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 37097594)

  • 41. Current respiratory syncytial virus prevention strategies in high-risk infants.
    Weisman LE
    Pediatr Int; 2002 Oct; 44(5):475-80. PubMed ID: 12225544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies.
    Lee Mortensen G; Harrod-Lui K
    Expert Rev Vaccines; 2022 Oct; 21(10):1523-1531. PubMed ID: 35929971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Respiratory syncytial virus infection and the need for immunization in Korea.
    Kim HY; Yun KW; Cheong HJ; Choi EH; Lee HJ
    Expert Rev Vaccines; 2023; 22(1):327-340. PubMed ID: 36960592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children.
    Li X; Bilcke J; Vázquez Fernández L; Bont L; Willem L; Wisløff T; Jit M; Beutels P;
    J Infect Dis; 2022 Aug; 226(Suppl 1):S95-S101. PubMed ID: 35292816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapy for respiratory tract infections caused by respiratory syncytial virus.
    van Woensel J; Kimpen J
    Eur J Pediatr; 2000 Jun; 159(6):391-8. PubMed ID: 10867842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infection.
    Receveur M; Ottmann M; Reynes JM; Eleouet JF; Galloux M; Receveur A; Ploin D; Fiorini S; Rivat N; Valette M; Lina B; Casalegno JS
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13025. PubMed ID: 36251946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The burgeoning burden of respiratory syncytial virus among children.
    Hall CB
    Infect Disord Drug Targets; 2012 Apr; 12(2):92-7. PubMed ID: 22335498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
    Sparrow E; Adetifa I; Chaiyakunapruk N; Cherian T; Fell DB; Graham BS; Innis B; Kaslow DC; Karron RA; Nair H; Neuzil KM; Saha S; Smith PG; Srikantiah P; Were F; Zar HJ; Feikin D
    Vaccine; 2022 Jun; 40(26):3506-3510. PubMed ID: 35184927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Respiratory syncytial virus immunisation overview.
    Foley DA; Phuong LK; Englund JA
    J Paediatr Child Health; 2020 Dec; 56(12):1865-1867. PubMed ID: 33089944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies.
    Ali A; Yousafzai MT; Waris R; Jafri F; Aziz F; Abbasi IN; Zaidi A
    J Med Virol; 2017 Jul; 89(7):1151-1157. PubMed ID: 28092107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.
    Zornoza Moreno M; Pérez Martín JJ; Moreno MCG; Abellán MPR
    Hum Vaccin Immunother; 2024 Dec; 20(1):2357439. PubMed ID: 38857859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New strategies for control of respiratory syncytial virus infection.
    Nokes JD; Cane PA
    Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Respiratory Syncytial Virus-An Update for Prenatal and Primary Health Providers.
    Kachikis AB; Cho H; Englund JA
    Obstet Gynecol Clin North Am; 2023 Jun; 50(2):421-437. PubMed ID: 37149320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lower respiratory tract illness and RSV prophylaxis in very premature infants.
    Lacaze-Masmonteil T; Truffert P; Pinquier D; Daoud P; Goldfarb G; Vicaut E; Fauroux B
    Arch Dis Child; 2004 Jun; 89(6):562-7. PubMed ID: 15155404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Profile of respiratory syncytial virus prefusogenic fusion protein nanoparticle vaccine.
    Blunck BN; Rezende W; Piedra PA
    Expert Rev Vaccines; 2021 Apr; 20(4):351-364. PubMed ID: 33733995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.
    Ueno F; Tamaki R; Saito M; Okamoto M; Saito-Obata M; Kamigaki T; Suzuki A; Segubre-Mercado E; Aloyon HD; Tallo V; Lupisan SP; Oshitani H;
    Influenza Other Respir Viruses; 2019 Jul; 13(4):339-353. PubMed ID: 30891896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
    Madhi SA; Polack FP; Piedra PA; Munoz FM; Trenholme AA; Simões EAF; Swamy GK; Agrawal S; Ahmed K; August A; Baqui AH; Calvert A; Chen J; Cho I; Cotton MF; Cutland CL; Englund JA; Fix A; Gonik B; Hammitt L; Heath PT; de Jesus JN; Jones CE; Khalil A; Kimberlin DW; Libster R; Llapur CJ; Lucero M; Pérez Marc G; Marshall HS; Masenya MS; Martinón-Torres F; Meece JK; Nolan TM; Osman A; Perrett KP; Plested JS; Richmond PC; Snape MD; Shakib JH; Shinde V; Stoney T; Thomas DN; Tita AT; Varner MW; Vatish M; Vrbicky K; Wen J; Zaman K; Zar HJ; Glenn GM; Fries LF;
    N Engl J Med; 2020 Jul; 383(5):426-439. PubMed ID: 32726529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention strategies for respiratory syncytial virus: passive and active immunization.
    Englund JA
    J Pediatr; 1999 Aug; 135(2 Pt 2):38-44. PubMed ID: 10431138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.
    Wang D; Bayliss S; Meads C
    Health Technol Assess; 2011 Jan; 15(5):iii-iv, 1-124. PubMed ID: 21281564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.